Heghine Khachatryan: New Evidence in Perioperative Hemostasis – Clinical Value of Perioperative TXA Use in General Surgery
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by JAMA Surgery on LinkedIn:
“New Evidence in Perioperative Hemostasis
A newly published systematic review and meta-analysis in JAMA Surgery highlights the clinical value of perioperative tranexamic acid (TXA) use in general surgery.
Key findings:
- Significant reduction in intraoperative blood loss
- Decreased transfusion requirements
- Lower incidence of major bleeding
- No observed increase in thromboembolic events
These data further support TXA as an effective and safe component of modern blood management strategies when used appropriately and with proper patient selection.
For hematologists, surgeons, anesthesiologists, and perioperative teams, this reinforces the importance of evidence-based antifibrinolytic use as part of multidisciplinary bleeding control and patient blood management (PBM) programs.
Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Published online: December 17, 2025 | JAMA Surgery
A meaningful step toward safer surgery, fewer transfusions, and better outcomes.”
Quoting JAMA Surgery’s post:
“Systematic review and meta-analysis: Prophylactic TXA use was associated with lower intraoperative blood loss, transfusion requirements, and major bleeding without an observed increase in thromboembolic or mortality risk.”
Title: Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Authors: Lucas Monteiro Delgado, Bernardo Fontel Pompeu, Gabriel Henrique Acedo Martins, Mariana Lima Azevedo, Eric Pasqualotto, Thiago Celestino Chulam, Sérgio Mazzola Poli de Figueiredo
Read the full article here.
Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Oct 14, 2026, 07:09Dianne E. van der Wal: A New Chapter in Academia Celebrating a Journey in Research, Teaching and Platelet Science
-
Oct 14, 2026, 06:55Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
-
Oct 14, 2026, 06:37Neoklis Mparis: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome During Bridging Anticoagulation
-
Oct 14, 2026, 06:00Aymen A.: LAAC vs. OAC in Patients with Atrial Fibrillation Including CHAMPION-AF and CLOSURE-AF Trials
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation
-
Oct 13, 2026, 21:01Alex Larson: Why Normal Bloodwork Does Not Always Tell the Whole Story
-
Oct 13, 2026, 20:58Juan Jauregui-Lozano: How Replication Stress Impairs Red Blood Cell Maturation
-
Oct 13, 2026, 20:55Caitlin Raymond: Understanding Platelet Refractoriness Before Ordering More Platelets